Skip to search formSkip to main contentSkip to account menu

CGS 26393

Known as: CGS-26393 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

OrganophosphonatesTetrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Protective effects of a dual endothelin converting enzyme/neutral endopeptidase inhibitor on the development of pulmonary hypertension secondary to cardiac dysfunction in the rat
Endothelium‐derived nitric oxide (NO) and endothelin (ET)‐1 interact to regulate the vascular tone in pulmonary hypertension (PH… 
2002
2002
Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
Increasing evidence has implicated endothelin-1 (ET-1), a potent vasoconstrictive peptide, in the pathophysiology of cerebral… 
2002
2002
Inhibition of endothelin-converting enzyme for protection against neointimal proliferation following balloon angioplasty of the rat carotid artery.
Clinical success of percutaneous transluminal coronary angioplasty is limited by restenosis within months of the initial… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)